Mr. McPhillips is Drug Substance Head for the WuXi Vaccines Manufacturing facility in Dundalk. This green field site will have manufacturing capability across Drug Substance and Drug Product (Formulation / Fill). The Vaccine manufacturing facility will be state of the art, maximizing the use of single use technologies to manufacture important vaccines for WuXi’s client. Mr. McPhillips is also interim Manufacturing Director for WuXi Biologics Drug Substance Manufacturing in Germany.
Before joining WuXi Mr. McPhillips held senior positions in manufacturing and technical operations for MSD and Wyeth.
Mr. McPhillips earned a BSc in Biological Sciences from Northeastern University, Boston, an MBA from NUIG and a Masters in Biopharmaceutical Engineering from UCD.